<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="12831" end="12838" sStart="12820" offset="11" sid="r8.suggest.v.0612" wn="3" wnkey="suggest%2:32:02::" text="These data suggest that in the unliganded state, hypophosphorylated RAR? can mimic the effects of RA on EGFR expression, ERK1 activity, and AP-1 protein levels." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-15.anc" start="25794" end="25798" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="Both authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="1951" end="1959" sStart="null" offset="319" sid="r11.function.n.0361" wn="3" wnkey="function%1:04:00::" text="In the RAR? amino terminus, a consensus mitogen activated protein kinase (MAPK) phosphorylation sequence was found to be a target of cyclin H and cdk7 [ 7 ] . RAR? was shown to bind the cyclin H/cdk7 complex in vitro and phosphorylation of serine 77 enhanced the transactivation function of RAR?." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="12356" end="12360" sStart="null" offset="74" sid="r9.fold.v.0729" wn="2147483645" wnkey="null" text="Following a similar time course, c-jun expression increased by 25 fold following stimulation by EGF." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="10166" end="10170" sStart="null" offset="55" sid="r9.fold.v.0265" wn="2147483645" wnkey="null" text="JunB expression was also decreased by up to 20 fold in mutant RAR? expressing cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8076" end="8080" sStart="null" offset="117" sid="r9.fold.v.0161" wn="2147483645" wnkey="null" text="6, expression of the G1 phase markers p21 WAF1/Cip1and p27 Kip1in the mutant RAR? clones was up to 3 fold higher compared to control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="4818" end="4822" sStart="null" offset="67" sid="r9.fold.v.0895" wn="2147483645" wnkey="null" text="1B, relative phosphorylation levels of RAR? decreased by 3 fold, similar to the reduction in cyclin H and cdk7 expression." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="r9.fold.v.0952" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="10032" end="10036" sStart="null" offset="50" sid="r9.fold.v.0672" wn="2147483645" wnkey="null" text="Expression of c-jun was reduced by 3 to 4 fold in the S77A RAR? cells compared to G418 resistant control clones." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="8205" end="8209" sStart="null" offset="82" sid="null" wn="2147483645" wnkey="null" text="In contrast, expression of the S phase marker cyclin A was decreased by 3 fold in two clones (RAR1 and 2) and was undetectable in 2 others (RAR3 and 4) when compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="4510" end="4514" sStart="null" offset="109" sid="r9.fold.v.0590" wn="" wnkey="null" text="1A, RA treatment decreased expression of both cyclin H and cdk7 in SCC4 and SCC25 cells by 3 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="6047" end="6054" sStart="null" offset="175" sid="r10.control.n.0649" wn="4" wnkey="control%1:09:02::" text="2, expression of the S77A mutant resulted in decreased relative phosphorylation of immunoprecipitated RAR? in stable clones compared to G418 resistant control cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="9835" end="9842" sStart="null" offset="222" sid="r10.control.n.0720" wn="4" wnkey="control%1:09:02::" text="To determine if reductions in AP-1 protein levels could account for the observed transcriptional inhibition by the S77A mutant RAR?, we compared expression of fos and jun proteins in G418 resistant control clones and S77A RAR? expressing cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="11366" end="11373" sStart="null" offset="121" sid="r10.control.n.0112" wn="4" wnkey="control%1:09:02::" text="Activated ERK1 in S77A mutant cells was expressed at less than 10% of the levels found in G418 resistant control clones." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="3928" end="3935" sStart="null" offset="62" sid="null" wn="2" wnkey="absence%1:04:00::" text=", by decreasing RAR? phosphorylation) and that in the absence of ligand, hypophosphorylated RAR? can mimic the molecular and cellular changes associated with retinoid treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="3928" end="3935" sStart="null" offset="62" sid="null" wn="1" wnkey="absence%1:26:00::" text=", by decreasing RAR? phosphorylation) and that in the absence of ligand, hypophosphorylated RAR? can mimic the molecular and cellular changes associated with retinoid treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="14526" end="14533" sStart="null" offset="80" sid="r11.absence.n.0821" wn="1" wnkey="absence%1:26:00::" text="The S77A RAR? mutant inhibited proliferation of SCC25 cells even in the absence of RA, thereby mimicking the growth inhibitory effect of the ligand." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="3928" end="3935" sStart="null" offset="62" sid="r11.absence.n.0566" wn="1" wnkey="absence%1:26:00::" text=", by decreasing RAR? phosphorylation) and that in the absence of ligand, hypophosphorylated RAR? can mimic the molecular and cellular changes associated with retinoid treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="3928" end="3935" sStart="null" offset="62" sid="null" wn="1" wnkey="absence%1:26:00::" text=", by decreasing RAR? phosphorylation) and that in the absence of ligand, hypophosphorylated RAR? can mimic the molecular and cellular changes associated with retinoid treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-15.anc" start="9126" end="9133" sStart="null" offset="15" sid="r11.absence.n.0606" wn="1" wnkey="absence%1:26:00::" text="In the absence of ligand, the S77A RAR? mutant inhibited AP-1 activity from this construct by 50%, similar to treatment with 1 ?M all trans RA (Fig." />
  </sentences>
</list>